NEW YORK, April 15, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of FLY Leasing Limited (“FLY Leasing”) (NYSE:FLY) between May 8, 2014 and March 7, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of New York. If you purchased or otherwise acquired FLY Leasing securities between May 8, 2014 and March 7, 2016, your rights may be affected by this action. To get more information go to: http://www.zlk.com/pslra/fly-leasing-limited.
The complaint alleges that during the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (a) during fiscal years 2014 and 2015 FLY Leasing engaged in improper accounting with respect to intangible assets and liabilities for aircraft required with in-place leases; and (b) as a result of the foregoing, FLY Leasing’s statements about the Company’s business, operations and prospects were materially false and misleading at all relevant times.
If you suffered a loss in FLY Leasing you have until May 24, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/fly-leasing-limited.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



